Approval of COVID-19 Vaccines Will Change Nature of Clinical Trials
Infectious disease experts agreed with ethicists that placebo-controlled trials would no longer be ethical, but said there are valid alternatives.
Related Articles
Eosinophilic Esophagitis Prevalence in the United States Reaches 1 in 700, Costing $1.32 Billion in Healthcare Annually
Eosinophilic esophagitis continues to increase in prevalence, with associated healthcare costs posing a substantial financial burden on patients and health systems.
A Multidisciplinary Approach to Identifying and Managing Cortisol Dysfunction
Explore the data showing us that hypercortisolism is more common than expected in cases of difficult-to-control diabetes and hypertension.
NICE Approves Sparsentan for Kidney Disease Treatment
NICE reversed its earlier decision on sparsentan for treating primary immunoglobulin A nephropathy after additional evidence and a price reduction from the manufacturer.
Syncope: Assessment and Referral
This summary includes assessment and referral recommendations on transient loss of consciousness (blackouts) in over 16s
How Pet Dogs Are Helping to Advance Lymphoma Breakthroughs
Collaborative studies among veterinarians and oncology researchers are yielding new insights into NHL, inspiring innovative treatment and prevention strategies for both dogs and people.
Diabetes Screening or Testing: Is Point-of-Care A1c Testing Ready for Prime Time?
Clinicians encourage patients to consider the benefits and risks of point-of-care A1c screening.
Deupirfenidone Shows Promise Against IPF-Linked Lung Decline
Tweaking the pirfenidone molecule yields an evidently effective but less toxic antifibrotic drug, investigators say.
Medscape
Clinical Integration of Therapeutic Innovations in Glioma: Pathways to Improved Patient Outcomes
Rare Allergy Triggered by K-Pop Dancing and Crab Consumption
Can dancing to K-pop or eating crabs trigger life-threatening allergic reactions? This rare case reveals an unusual and complex medical phenomenon.